Anavex’s precision medicine approach recognizes that Alzheimer’s pathology is heterogeneous, but autophagy dysfunction represents a causative co-factor that precedes divergent downstream ...

Anavex Life Sciences Corp. AVXL on Friday announced that a new peer-reviewed study published by the University of California in Proceedings of the National Academy of Sciences, Nexus supports the ...

Brain aging typically starts when our midlife does—around age 40. Previous research has continued to suggest that our brain ...

A new review study explains that extremophiles have revolutionized medicine, and are invaluable allies in the fight against ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that preclinical data from its IL ...

KT501 is engineered to target a broad spectrum of B-cell populations, including plasma cells, by simultaneously binding to CD19 and BCMA. Unlike traditional B-cell therapies, KT501 is designed to ...

Advanced proteomics and AI reveal blood protein changes, offering insights into early Alzheimer's detection and differentiation from mild cognitive impairment.

New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes. NOVATO, Calif., March 17, 2026 /PRNewswire/ -- ...

"Many people notice sleep getting lighter and more fragmented in midlife, then it becomes much more common after about age 60." ...

Duchenne muscular dystrophy (DMD) is a severe X-linked myopathy characterised by progressive skeletal and cardiac muscle degeneration, loss of ambulation, respiratory failure and premature mortality.

Once absorbed by the body, EDCs — doppelganger hormones — have free rein to decrease or increase normal hormone levels, or alter natural hormone production. Thus, EDCs thrift Hermes’ messenger bag and ...